… A 15-year-old girl with familial Mediterranean fever (FMF) was admitted to our hospital
because of the persistence of recurrent fever attacks (twice a month), accompanied by chest and …

… of colchicine-resistant FMF patients with anakinra were published [3,4]. Anakinra is an …
Since knowledge about the efficacy and tolerance of anakinra is rare we herein present two …

… efficacy and safety of anti-interleukin 1 (anti-IL1) and anti-tumor necrosis factor agents in
colchicine-resistant … Anakinra is generally favored as an initial approach due to its short half-life, …

… proinflammatory cytokines in familial Mediterranean fever (FMF)… the efficacy and safety
of canakinumab in all adolescent and … is the good efficacy of canakinumab in 5 anakinra-resistant …

… case reports of patients treated with either anakinra or canakinumab have suggested the
potential efficacy of IL-1 blockade in colchicine-resistant patients and those with amyloidosis [5, …

… Shortly after that, the efficacy of Anakinra in the treatment of a colchicine resistant 68 year
old woman homozygous for the M694 V mutation of the MEFV gene [43] and a 15 year-old …

… -alpha, thalidomide and etanercept, have been used with limited response [3, 4]. Anakinra
is a … We report here the efficacy of anakinra in a renal transplant patient with FMF, who had …

… colchicine-resistant. We report the effect of anti-tumor necrosis factor therapy (etanercept) and
anti-interleukin 1 (IL-1) treatment (anakinra) … for children and adolescents, and all received …

… The aim of the present study was to assess the efficacy and safety of anakinra for the treatment
of colchicine-resistant … in children and adolescents. Rheumatol Int 2015;35:1733–7. 30. …

… treatment of patients with colchicine-resistant FMF and FMF patients … was observed after
initiation of anakinra. In five patients, … in adolescents and adults with colchicine-resistant familial …